DXTERA INSTITUTE, INC – Trademark Portfolio
Entity Type: 03
DXTERA INSTITUTE, INC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DXTERA and EDSAFE AI ALLIANCE. The owner is based in Indianapolis, IN.
9998 CROSSPOINT BLVD
Indianapolis, IN 46256
Showing of trademarks Trademarks
Trademark Classifications
DXTERA INSTITUTE, INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does DXTERA INSTITUTE, INC have?
DXTERA INSTITUTE, INC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does DXTERA INSTITUTE, INC file in?
DXTERA INSTITUTE, INC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are DXTERA INSTITUTE, INC's most well-known trademarks?
DXTERA INSTITUTE, INC's registered trademark portfolio includes well-known marks such as DXTERA and EDSAFE AI ALLIANCE. These are among 3 currently registered trademarks in the portfolio.
What is DXTERA INSTITUTE, INC's trademark registration success rate?
DXTERA INSTITUTE, INC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.